HIGHLIGHTS
- who: Huib Ovaa and Fred van Leeuwen from the Division of Gene Regulation, Cancer Institute, Leiden Institute for Immunology, Oncode Institute, Leiden University Medical Center, Leiden, Division of Biochemistry, University of Pisa, Italy have published the article: Strategy for Development of Site-Specific Ubiquitin Antibodies, in the Journal: (JOURNAL)
- what: As evidenced by the small number of good antibodies this approach has not always been successful. In section Anticipated Results the authors show how the conjugates are used for screening and clone selection in steps and the authors provide examples of validation experiments for step . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.